Advertisement
American Journal of Infection Control
Advanced searchSave search
Major article| Volume 42, ISSUE 12, P1274-1277, December 2014

Impact of universal disinfectant cap implementation on central line–associated bloodstream infections

DOI:https://doi.org/10.1016/j.ajic.2014.09.008
Impact of universal disinfectant cap implementation on central line–associated bloodstream infections
Previous ArticleSuccessful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance
Next ArticleMeta-analysis on central line–associated bloodstream infections associated with a needleless intravenous connector with a new engineering design

      Background

      Central line–associated bloodstream infections (CLABSIs) result in increased length of stay, cost, and patient morbidity and mortality. One CLABSI prevention method is disinfection of intravenous access points. The literature suggests that placing disinfectant caps over needleless connectors decreases CLABSI risk.

      Methods

      A quasi-experimental intervention study was conducted in a >430-bed trauma I center. In addition to an existing standard central line bundle, a new intervention consisting of a luer-lock disinfectant cap with 70% alcohol was implemented in all intravenous (IV) needleless connectors on patients with peripheral and central lines. Compliance to the disinfectant cap was monitored weekly. A generalized linear model using a Poisson distribution was fit to determine if there were significant relationships between CLABSIs and disinfectant cap use. Impacts on costs were also examined.

      Results

      The rate of CLABSI decreased following implementation of the disinfectant cap. The incidence rate ratios (.577, P = .004) for implementing the disinfectant caps was statistically significant, indicating that the rate of patient infections decreased by >40%. Increased compliance rates were associated with lower infection rates. Disinfectant cap use was associated with an estimated savings of almost $300,000 per year in the hospital studied.

      Conclusions

      Use of a disinfectant cap on IV needleless connectors in addition to an existing standard central line bundle was associated with decreased CLABSI and costs.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

      1. Shekelle PG, Wachter RM, Pronovost PJ, Schoelles K, McDonald KM, Dy SM, et al. Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Agency for Healthcare Research and Quality Web site. 2013. Available from: http://www.ahrq.gov/research/findings/evidence-based-reports/ptsafetyuptp.html. Accessed May 22, 2014.

        View in Article
        • Sagana R.
        • Hyzy R.C.
        Achieving zero central line–associated bloodstream infection: rates in your intensive care unit.
        Crit Care Clin. 2013; 29: 1-9
        View in Article

      3. O'Grady NP, Alexander M, Burns LA, Dellinger P, Garland J, Heard SO, et al. Guidelines for prevention of intravascular catheter-related infections, 2011. Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdf. Accessed April 23, 2014.

        View in Article
        • Marschall J.
        • Mermel L.A.
        • Classen D.
        • Arias K.M.
        • Podgorny K.
        • Anderson D.J.
        • et al.
        Strategies to prevent central line-associated bloodstream.
        Infect Control Hosp Epidemiol. 2008; 29: S22-S30
        View in Article
        • Jeffries H.E.
        • Mason W.
        • Brewer M.
        • Oakes K.L.
        • Muñoz E.I.
        • Gornick W.
        • et al.
        Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative.
        Infect Control Hosp Epidemiol. 2009; 30: 645-651
        View in Article
        • Shannon R.P.
        • Patel B.
        • Cummins D.
        • Shannon A.H.
        • Ganguli G.
        • Lu Y.
        Economics of central line-associated bloodstream infections.
        Am J Med Qual. 2006; 21: 7S-16S
        View in Article

      7. Doellman D. The role of technology in reducing risks associated with CRBSI. Ivera Medical Corporation Web site. Available from: www.iveramed.com (2011). http://www.curos.com/wp-content/uploads/CRBSI-White-Paper_-Darcy-Doellman.pdf. Accessed May 22, 2014.

        View in Article
        • Menyhay S.Z.
        • Maki D.B.
        Disinfection of needless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap.
        Infect Control Hosp Epidemiol. 2006; 17: 23-27
        View in Article
        • Oto J.
        • Imanaka H.
        • Konno M.
        • Nakataki E.
        • Nishimura M.
        A prospective clinical trial on prevention of catheter contamination using the hub protection cap for needleless injection device.
        Am J Infect Control. 2011; 39: 309-313
        View in Article
        • McAfee N.
        • Seidel K.
        • Watkins S.
        • Flynn J.T.
        A continuous quality improvement project to decrease hemodialysis catheter infections in pediatric patients: use of a closed luer-lock access cap.
        Nephrol Nurs J. 2010; 37: 541-544
        View in Article
        • Wright M.O.
        • Tropp J.
        • Schora D.M.
        • Dillon-Grant M.
        • Peterson K.
        • Boehm S.
        • et al.
        Continuous passive disinfection of catheter hubs prevents contamination and bloodstream infection.
        Am J Infect Control. 2013; 4: 33-38
        View in Article
        • Shadish W.R.
        • Cook T.D.
        • Campbell D.T.
        Experimental and quasi-experimental designs for generalized causal inference.
        Houghton Mifflin, Boston [MA]2002
        View in Article

      13. Food and Drug Administration. Ivera Medical Curos 510(k) notification. (2012). Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf11/K111992.pdf. Accessed May 22, 2014.

        View in Article
        • Latif A.
        • Majid H.
        • Mahmood F.
        • Pronovost P.
        • Dowdy D.
        Cost effectiveness of reducing CLABSI in the limited resource setting of developing countries.
        Crit Care Med. 2013; 41: s122-s123
        View in Article
        • IBM Corp
        IMB SPSS statistics for Windows, Version 22.0.
        IBM Corp, Armonk [NY]2013
        View in Article
        • Hilbe J.M.
        Negative binomial regression.
        2nd ed. Cambridge University Press, New York [NY]2011
        View in Article
        • Blot K.
        • Bergs J.
        • Vogelaers D.
        • Blot S.
        • Vandijck D.
        Prevention of central-line associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis.
        Clin Infect Dis. 2014; 59: 96-105
        View in Article
        • Sweet M.A.
        • Cumpston A.
        • Briggs F.
        • Hamadani C.M.
        Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit.
        Am J Infect Control. 2012; 40: 931-934
        View in Article

      19. Johns Hopkins Medicin, Armstrong Institute for Patient Safety and Quality. CLABSI toolkit. 2008; Available from: http://www.hopkinsmedicine.org/armstrong_institute/improvement_projects/stop_bsi/clabsi_toolkit.html. Accessed May 20, 2014.

        View in Article

      Article info

      Footnotes

      Conflicts of interest: None to report.

      Identification

      DOI: https://doi.org/10.1016/j.ajic.2014.09.008

      Copyright

      © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX